We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$574M
AUM Growth
+$51.8M
Cap. Flow
+$390K
Cap. Flow %
0.07%
Top 10 Hldgs %
50.16%
Holding
79
New
7
Increased
29
Reduced
31
Closed
1

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.05M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$837K
3
RTX icon
RTX Corp
RTX
+$826K
4
MNST icon
Monster Beverage
MNST
+$807K
5
V icon
Visa
V
+$635K

Top Sells

Rank Stock Value
1
PAYX icon
Paychex
PAYX
+$2.77M
2
AAPL icon
Apple
AAPL
+$2.05M
3
NVDA icon
NVIDIA
NVDA
+$583K
4
ADP icon
Automatic Data Processing
ADP
+$361K
5
MCD icon
McDonald's
MCD
+$256K

Sector Composition

Rank Sector Weight
1 Technology 29.6%
2 Healthcare 19.13%
3 Communication Services 12.43%
4 Consumer Discretionary 11.43%
5 Financials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
51
Amgen
AMGN
$208B
$658K 0.11%
2,924
+120
+4% +$25.3K
ETN icon
52
Eaton
ETN
$161B
$652K 0.11%
3,766
+15
+0.4% +$2.49K
TGT icon
53
Target
TGT
$65.6B
$617K 0.11%
2,673
-167
-6% -$40.6K
UNH icon
54
UnitedHealth
UNH
$376B
$596K 0.1%
1,187
+43
+4% +$19.5K
K
55
DELISTED
Kellanova
K
$539K 0.09%
8,967
CMG icon
56
Chipotle Mexican Grill
CMG
$47.2B
$512K 0.09%
14,650
GNRC icon
57
Generac Holdings
GNRC
$11.6B
$474K 0.08%
1,346
+581
+76% +$241K
MRK icon
58
Merck
MRK
$322B
$399K 0.07%
5,176
-1,895
-27% -$151K
AZN icon
59
AstraZeneca
AZN
$263B
$387K 0.07%
+3,333
New +$392K
CSCO icon
60
Cisco
CSCO
$457B
$385K 0.07%
6,110
-50
-0.8% -$2.86K
EMR icon
61
Emerson Electric
EMR
$83.9B
$359K 0.06%
3,857
-50
-1% -$4.71K
INTC icon
62
Intel
INTC
$455B
$317K 0.06%
+6,089
New +$311K
BDX icon
63
Becton Dickinson
BDX
$45.6B
$291K 0.05%
1,190
-63
-5% -$15.1K
KO icon
64
Coca-Cola
KO
$377B
$286K 0.05%
4,842
UPS icon
65
United Parcel Service
UPS
$88.6B
$280K 0.05%
1,308
+15
+1% +$3.05K
NEO icon
66
NeoGenomics
NEO
$1.96B
$272K 0.05%
8,000
MRSH
67
Marsh
MRSH
$90.5B
$269K 0.05%
1,548
COST icon
68
Costco
COST
$422B
$251K 0.04%
+442
New +$226K
BMY icon
69
Bristol-Myers Squibb
BMY
$133B
$245K 0.04%
3,955
-463
-10% -$27.2K
USB icon
70
US Bancorp
USB
$98.2B
$245K 0.04%
4,377
+500
+13% +$29.6K
COF icon
71
Capital One
COF
$128B
$239K 0.04%
1,650
HBAN icon
72
Huntington Bancshares
HBAN
$34.4B
$227K 0.04%
15,139
UNP icon
73
Union Pacific
UNP
$174B
$224K 0.04%
+889
New +$211K
PFE icon
74
Pfizer
PFE
$143B
$221K 0.04%
+3,754
New +$186K
ALGN icon
75
Align Technology
ALGN
$12.1B
$217K 0.04%
330
+10
+3% +$6.43K

Similar funds

Dillon & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Dillon & Associates held 79 positions worth $574M, up 9.9% from $522M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Dillon & Associates's Q4 2021 filing shows 7 new, 29 increased, 31 reduced and 1 closed positions. Its largest new stake was Monster Beverage: 18,160 shares worth $872K. The largest sale was Paychex, an estimated $2.77M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Dillon & Associates's largest Q4 2021 buy was Monster Beverage: 18,160 shares worth $872K.
  • Dillon & Associates added most to PayPal in Q4 2021, an estimated $1.05M increase.
  • Dillon & Associates's biggest Q4 2021 reduction was Paychex, cutting an estimated $2.77M.
  • Dillon & Associates fully exited Walgreens Boots Alliance in Q4 2021, selling an estimated $247K.
  • Dillon & Associates's ten largest holdings make up 50% of its $574M portfolio in Q4 2021.
  • Dillon & Associates opened 7 new positions and closed 1 in Q4 2021.
  • Dillon & Associates's portfolio value rose 9.9% quarter-over-quarter to $574M.

Based on Dillon & Associates's 13F filing for Q4 2021, filed 14 Feb 2022.